drugset / Trial / NCT00924729

Study of Ocular Penetration of Topically Administered Fluoroquinolones

NCT00924729

Phase 4 Completed 50 enrolled Johns Hopkins University
RandomizedParallel-groupQuadruple-blindOther

Summary

This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Timeline

Start
2009-09
Primary completion
2009-10
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Besifloxacin Small molecule 0.6 % Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical

Indications